HeartSciences Income Statement (2021-2025) | HSCS

Income Statement Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025
Revenue & cost
Revenue 0.01M0.00M0.00M0.00M0.00M-0.04M0.00M0.01M-0.02M-0.12M-0.18M-0.18M0.00M0.00M
Cost of Revenue 0.01M854.000.00M0.00M760.000.00M0.00M0.10M0.10M760.000.00M
Gross Profit 0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.00M0.00M
Operating items
Research & Development 0.40M0.55M0.70M1.36M0.43M0.85M0.64M0.53M0.57M0.76M0.51M1.05M1.22M1.20M1.03M0.93M1.00M0.73M
Selling, General & Administrative 0.28M0.41M0.40M0.63M1.00M0.93M0.67M1.06M0.77M0.82M1.03M0.83M0.85M0.79M1.34M0.99M0.88M1.35M
Operating Expenses 0.68M0.96M1.10M1.98M1.43M1.77M1.31M1.60M1.33M1.57M1.54M1.88M2.08M1.99M2.37M1.92M1.88M2.07M
Operating Income -0.67M-0.96M-1.10M-1.98M-1.43M-1.77M-1.31M-1.60M-1.33M-1.57M-1.53M-1.88M-2.08M-1.99M-2.37M-1.92M-1.87M-2.07M
EBIT -0.67M-0.96M-1.10M-1.98M-1.43M-1.77M-1.31M-1.60M-1.33M-1.57M-1.53M-1.88M-2.08M-1.99M-2.37M-1.92M-1.87M-2.07M
Non-operating items
Other Non Operating Income 0.25M851.00401.000.00M255.0060.003.0016.000.05M0.05M0.02M0.01M0.01M0.00M0.00M
Non Operating Income 0.17M-0.08M-0.14M-0.08M-0.14M-0.03M-0.03M-0.03M-0.04M-0.18M-0.12M0.03M0.02M-0.10M-0.16M-0.17M-0.18M-0.28M
Net income details
EBT -0.75M-1.03M-1.24M-2.05M-1.57M-1.81M-1.34M-1.63M-1.37M-1.75M-1.64M-1.90M-2.10M-2.10M-2.55M-2.10M-2.06M-2.35M
Profit After Tax -0.50M-1.03M-1.24M-2.05M-1.57M-1.81M-1.34M-1.63M-1.37M-1.75M-1.64M-1.85M-2.05M-2.08M-2.54M-2.09M-2.05M-2.35M
Income from Continuing Operations -0.75M-1.03M-1.24M-2.05M-1.57M-1.81M-1.34M-1.63M-1.37M-1.75M-1.64M-1.90M-2.10M-2.10M-2.55M-2.10M-2.06M-2.35M
Consolidated Net Income -0.75M-1.03M-1.24M-2.05M-1.57M-1.81M-1.34M-1.63M-1.37M-1.75M-1.64M-1.90M-2.10M-2.10M-2.55M-2.10M-2.06M-2.35M
Income towards Parent Company -0.75M-1.03M-1.24M-2.05M-1.57M-1.81M-1.34M-1.63M-1.37M-1.75M-1.64M-1.90M-2.10M-2.10M-2.55M-2.10M-2.06M-2.35M
Net Income towards Common Stockholders -0.75M-1.03M-1.24M-2.05M-1.57M-1.81M-1.34M-1.63M-1.37M-1.75M-1.64M-1.90M-2.10M-2.10M-2.55M-2.10M-2.06M-2.35M
Additional items
EPS (Basic) -0.15-0.31-0.37-0.61-0.28-0.22-0.16-79.36-13.23-15.92-3.010.11-2.64-2.27-2.57-2.24-1.58-0.85
EPS (Weighted Average and Diluted) -0.15-0.31-0.37-0.61-0.28-0.22-0.16-79.36-13.23-15.92-3.010.11-2.64-2.27-2.57-2.24-1.58-0.85
Shares Outstanding (Weighted Average) 740.003.31M3.31M3.32M3.32M5.65M8.21M8.24M0.08M0.10M0.11M0.55M0.35M0.78M0.92M0.99M0.94M1.30M2.78M
Shares Outstanding (Diluted Average) 3.31M3.31M3.32M3.32M5.65M8.21M8.24M0.08M0.10M0.11M0.55M0.35M0.78M0.92M0.99M0.94M1.30M2.78M
EBITDA -0.67M-0.96M-1.10M-1.98M-1.43M-1.77M-1.31M-1.60M-1.33M-1.57M-1.53M-1.88M-2.08M-1.99M-2.37M-1.92M-1.87M-2.07M
Interest Expenses 0.08M0.08M0.14M0.08M0.14M0.03M0.03M0.03M0.04M0.18M0.12M0.02M0.02M0.12M0.18M0.18M0.18M0.28M